http://www.unboundmedicine.com/medline/ebm/research/CombivirUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19859531/full_citation/Efficacy_of_Short_Course_AZT_Plus_3TC_to_Reduce_Nevirapine_Resistance_in_the_Prevention_of_Mother_to_Child_HIV_Transmission:_A_Randomized_Clinical_Trial_McIntyre JA, Hopley M, Moodley D, et al. 
Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial. [JOURNAL ARTICLE]
PLoS Med 2009 Oct; 6(10):e1000172.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19236820/full_citation/Non_occupational_postexposure_prophylaxis_for_HIV:_a_systematic_review_Bryant J, Baxter L, Hird S 
Non-occupational postexposure prophylaxis for HIV: a systematic review. [Journal Article]
Health Technol Assess 2009 Feb; 13(14):1-82.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19227559/full_citation/Switching_Combivir_to_Truvada_keeps_HIV_undetectable_improves_blood_fats_fails_to_improve_limb_fat_Switching Combivir to Truvada keeps HIV undetectable, improves blood fats, fails to improve limb fat. [Newspaper Article]
Proj Inf Perspect 2008 Dec; (47):8.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19075055/full_citation/Virologic_Failure_in_First_Line_HIV_Therapy_with_a_CCR5_Entry_Inhibitor__Aplaviroc/Combivir_CCR102881_:_NRTI_Resistance_Regardless_of_Envelope_Tropism_Demarest JF, Amrine-Madsen H, Irlbeck DM, et al. 
Virologic Failure in First Line HIV Therapy with a CCR5 Entry Inhibitor (Aplaviroc/Combivir, CCR102881): NRTI Resistance Regardless of Envelope Tropism. [JOURNAL ARTICLE]
Antimicrob Agents Chemother 2008 Dec 15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18988678/full_citation/Effectiveness_and_safety_of_didanosine_lamivudine_and_efavirenz_versus_zidovudine_lamivudine_and_efavirenz_for_the_initial_treatment_of_HIV_infected_patients_from_the_Spanish_VACH_cohort_Crespo M, Ribera E, Suárez-Lozano I, et al. 
Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort. [JOURNAL ARTICLE]
J Antimicrob Chemother 2008 Nov 6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18974011/full_citation/The_Use_of_Shift_Reagents_in_Ion_Mobility_Mass_Spectrometry:_Studies_on_the_Complexation_of_an_Active_Pharmaceutical_Ingredient_with_Polyethylene_Glycol_Excipients_Howdle MD, Eckers C, Laures AM, et al. 
The Use of Shift Reagents in Ion Mobility-Mass Spectrometry: Studies on the Complexation of an Active Pharmaceutical Ingredient with Polyethylene Glycol Excipients. [JOURNAL ARTICLE]
J Am Soc Mass Spectrom 2008 Oct 9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18955917/full_citation/HIV_Postexposure_Prophylaxis_After_Sexual_Assault:_Why_Is_It_So_Hard_to_AccomplishCohen MS 
HIV Postexposure Prophylaxis After Sexual Assault: Why Is It So Hard to Accomplish? [JOURNAL ARTICLE]
Sex Transm Dis 2008 Oct 24.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18505181/full_citation/Antiviral_activity_and_safety_of_aplaviroc_with_lamivudine/zidovudine_in_HIV_infected_therapy_naive_patients:_the_ASCENT__CCR102881__study_Currier J, Lazzarin A, Sloan L, et al. 
Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study. [Journal Article, Research Support, Non-U.S. Gov't]
Antivir Ther 2008; 13(2):297-306.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18472979/full_citation/The_renaissance_of_fixed_dose_combinations:_Combivir_Portsmouth SD, Scott CJ 
The renaissance of fixed dose combinations: Combivir. [Journal Article]
Ther Clin Risk Manag 2007 Aug; 3(4):579-83.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18456190/full_citation/Other_potential_medical_therapies:_the_use_of_antiviral_agents_to_investigate_and_treat_primary_ciliary_cirrhosis_Mason AL, Wasilenko ST 
Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis. [Journal Article]
Clin Liver Dis 2008 May; 12(2):445-60.
Abstract | Full Citation